×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Semorinemab (RG6100)
therapeutic
2,319 words
KG: Semorinemab (RG6100)
2026-03-26
kind:therapeutic
section:therapeutics
topic:alzheimers
topic:tauopathies
Contents
Semorinemab (RG6100)
💊
Therapeutic Info
Name
Semorinemab (RG6100)
Summary
Anti-tau monoclonal antibody therapy for Alzheimer's disease and tauopathies - mechanism, clinical trials, and outcomes
Knowledge Graph
Related Hypotheses (9)
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Microglial Purinergic Reprogramming
Score: 0.48
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55
Dual-Circuit Tau Vulnerability Cascade
Score: 0.50
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Show 4 more
Related Analyses (4)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Related Experiments (7)
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90
Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80
Anti-Tau Immunotherapy Dosing Optimization
clinical · proposed · Score: 0.40
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40
Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.40
Tau Propagation Causality Test — Does Tau Spread Drive Neuro
clinical · proposed · Score: 0.40
Show 2 more
Key Papers (1)
Randomized control trial of evaluation of Clemastine effects on visual
Clinical neurology and neurosu 2020
See Also (15)
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 5 hypotheses
RNA-Targeted Therapies in Neurodegeneration
mechanism · Pages share 5 hypotheses
PPAR Signaling Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Neurovascular Unit Dysfunction in Neurodegeneration
mechanism · Pages share 5 hypotheses
Endosomal Sorting Defects in Neurodegeneration
mechanism · Pages share 5 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Cerebral Amyloid Angiopathy Pathway in Neurodegeneratio
mechanism · Pages share 5 hypotheses
Cerebral Amyloid Angiopathy in Neurodegeneration
mechanism · Pages share 5 hypotheses
Extracellular Vesicle and Tunneling Nanotube-Mediated S
mechanism · Pages share 5 hypotheses
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 4 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 4 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 4 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 4 hypotheses
Show 10 more